| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 2781 | 0.4133 |
| 1 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 3030 | 0.3379 |
| 2 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1662 | 0.1655 |
| 3 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 7181 | 0.1581 |
| 4 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 1632 | 0.1429 |
| 5 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 373 | 0.1354 |
| 6 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 462 | 0.1285 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 36 | 0.0130 |
| 8 | ATAZANAVIR AND COBICISTAT | 3 | 0.0122 |
| 9 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 4 | 0.0101 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7941 | 0.0721 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 4202 | 0.0695 |
| 2 | Protease Inhibitor [EPC] | 557 | 0.0125 |
| 3 | Antidiarrheal [EPC] | 1 | 0.0042 |
| 4 | alpha-Hydroxy Acid [EPC] | 6 | 0.0028 |
| 5 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 6 | Sulfonamide Antibacterial [EPC] | 6 | 0.0015 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 63 | 0.0013 |
| 8 | Calcitonin [EPC] | 3 | 0.0010 |
| 9 | Estrogen Receptor Antagonist [EPC] | 38 | 0.0009 |